Narrow search
Showing 1 - 10 of 126
Cover Image
Election Systems, the "Beauty Premium" in Politics, and the Beauty of Dissent
Potrafke, Niklas - 2020
We ask three questions. First, do election systems differ in how they translate physical attractiveness of candidates into electoral success? Second, do political parties strategically exploit the "beauty premium" when deciding on which candidates to nominate, and, third, do elected MPs use...
Persistent link: https://www.econbiz.de/10012833726
Cover Image
"Beauty Too Rich for Use" : Billionaires' Assets and Attractiveness
Hamermesh, Daniel; Leigh, Andrew - 2021
We examine how the net worth of billionaires relates to their looks, as rated by 16 people of different gender and ethnicity. Surprisingly, their financial assets are unrelated to their beauty; nor are they related to their educational attainment. As a group, however, billionaires are both more...
Persistent link: https://www.econbiz.de/10013323870
Cover Image
The Global Costs of Extreme Weather that are Attributable to Climate Change
Newman, Rebecca; Noy, Ilan - 2022
Extreme weather events have significant adverse costs for individuals, firms, communities, regional, and national economies. Extreme Event Attribution (EEA), a methodology that examines the degree to which anthropogenic greenhouse gas emissions had changed the occurrence of specific extreme...
Persistent link: https://www.econbiz.de/10014242787
Cover Image
One chance in a million: altruism and the bone marrow registry
Bergstrom, Ted; Garratt, Rod; Sheehan-Connor, Damien - 2007
Transplants of donated stem cells save the lives of many patients with blood diseases. Donation is somewhat painful, but rarely has lasting adverse effects. Patients can accept transplants only from donors with compatible immune systems. Those lacking a sibling match must seek donations from the...
Persistent link: https://www.econbiz.de/10010264202
Cover Image
Dynamic Mergers Effects on R&D Investments and Drug Development Across Research Phases in the Pharmaceutical Industry
Siebert, Ralph - 2020
Pharmaceutical firms spend increasing amounts in mergers and acquisitions (M&As), which raises the question of whether sufficient investment is left after mergers to further develop firms' internal drug development capability. We evaluate the effects of M&As on firms' post-merger R&D investments...
Persistent link: https://www.econbiz.de/10012833741
Cover Image
Pricing the Pharmaceuticals When the Ability to Pay Differs : Taking Vertical Equity Seriously
Kanniainen, Vesa - 2020
, the paper analyzes the public insurance of the pharmaceutical products in terms of price controls and the socially optimal … third-degree price discrimination. It characterizes first the Ramsey pricing rule in the absence of insurance and in the … departure from Ramsey pricing are stated in terms of price regulation and insurance coverage. The resulting outcome is second …
Persistent link: https://www.econbiz.de/10012843430
Cover Image
The Impact of New Drug Launches on Hospitalization in 2015 for 67 Medical Conditions in 15 OECD Countries : A Two-Way Fixed-Effects Analysis
Lichtenberg, Frank R. - 2019
There are two types of prescription drug cost offsets. The first type of cost offset—from prescription drug use—is primarily about the effect of changes in drug quantity (e.g. due to changes in out-of-pocket drug costs) on other medical costs. The second type of cost offset—the cost offset...
Persistent link: https://www.econbiz.de/10012889758
Cover Image
The Patent Buyout Price for Human Papilloma Virus (HPV) Vaccine and the Ratio of R&D Costs to the Patent Value
Songane, Mario - 2020
Human papillomavirus (HPV) is responsible for almost all of the 570,000 new cases of cervical cancer and approximately 311,000 deaths per year. HPV vaccination is an integral component of the World Health Organization's (WHO) global strategy to fight the disease. However, high vaccine prices...
Persistent link: https://www.econbiz.de/10012825394
Cover Image
Pharmaceutical Prices : The Impact of the Launch Strategy - An Analysis of German Data
Böhler, Yvonne-Beatrice - 2019
pricing system was changed in 2011 in order to tie prices more to the benefits of the pharmaceuticals. A multiple linear … regression of 187 pharmaceuticals which were assessed from 2011 to 2017 suggests that, despite the change, the manufacturers …
Persistent link: https://www.econbiz.de/10012860771
Cover Image
Vaccination Lottery
Kim, Duk Gyoo - 2021
Ohio announced a Vax-a-Million Lottery in May 2021 to encourage people vaccinated. If people may avoid vaccination because (1) they worry about rare but critical side effects or (2) they want to free ride on herd immunity, the vaccination lottery may work better or worse than a lump-sum transfer...
Persistent link: https://www.econbiz.de/10013216770